{"schema_version":"secwatch.filing_event.v1","accession":"0001396814-25-000055","form_type":"8-K","ticker":"PCRX","cik":"0001396814","company_name":"Pacira BioSciences, Inc.","filed_at":"2025-04-22T23:59:59+00:00","discovered_at":"2026-05-14T18:02:48.158775+00:00","generated_at":"2026-05-23T09:11:05.281733+00:00","sec_items":["8.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Pacira Biosciences authorizes $300M share repurchase program through Dec 31, 2026","bullets":["Board approved $300M stock buyback, effective immediately, replacing the May 7, 2024 program.","Repurchases may be made on open market or via privately negotiated transactions at management's discretion.","Program expires December 31, 2026; can be suspended or discontinued at any time by the company.","No obligation to repurchase any specific number of shares under the authorization."],"urls":{"canonical":"https://secwatch.observer/filing/0001396814-25-000055","json":"https://secwatch.observer/filing/0001396814-25-000055.json","markdown":"https://secwatch.observer/filing/0001396814-25-000055.md","text":"https://secwatch.observer/filing/0001396814-25-000055.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1396814/000139681425000055/0001396814-25-000055-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1396814/000139681425000055/pcrx-20250417.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-23T09:11:05.281733+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}